Absci announces closing of public offering of common stock including full exercise of the underwriters' option to purchase additional shares

Vancouver, wash., march 01, 2024 (globe newswire) -- absci corporation (nasdaq: absi) (“absci”), a data-first generative ai drug creation company, today announced the closing of its underwritten public offering of 19,205,000 shares of its common stock at a public offering price of $4.50 per share, before deducting underwriting discounts and commissions. the shares of common stock include 2,505,000 shares pursuant to the option granted by absci to the underwriters, which was exercised in full. the gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $86.4 million. all of the shares in the offering were sold by absci.
ABSI Ratings Summary
ABSI Quant Ranking